These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 1975421)

  • 1. Interactions of glucagon and free fatty acids with insulin in control of glucose metabolism.
    Chambrier C; Picard S; Vidal H; Cohen R; Riou JP; Beylot M
    Metabolism; 1990 Sep; 39(9):976-84. PubMed ID: 1975421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
    Orskov L; Alberti KG; Mengel A; Møller N; Pedersen O; Rasmussen O; Seefeldt T; Schmitz O
    Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of somatostatin on nonesterified fatty acid levels modifies glucose homeostasis during fasting.
    Hendrick GK; Frizzell RT; Cherrington AD
    Am J Physiol; 1987 Oct; 253(4 Pt 1):E443-52. PubMed ID: 2889364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans.
    Roden M; Stingl H; Chandramouli V; Schumann WC; Hofer A; Landau BR; Nowotny P; Waldhäusl W; Shulman GI
    Diabetes; 2000 May; 49(5):701-7. PubMed ID: 10905476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise-induced fall in insulin: mechanism of action at the liver and effects on muscle glucose metabolism.
    Zinker BA; Mohr T; Kelly P; Namdaran K; Bracy DP; Wasserman DH
    Am J Physiol; 1994 May; 266(5 Pt 1):E683-9. PubMed ID: 7911275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon does not increase plasma free fatty acid and glycerol concentrations in patients with noninsulin-dependent diabetes mellitus.
    Jeng CY; Sheu WH; Jaspan JB; Polonsky KS; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1993 Jul; 77(1):6-10. PubMed ID: 8100832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ketone bodies on glucose production and utilization in the miniature pig.
    Müller MJ; Paschen U; Seitz HJ
    J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of basal glucagon levels in the regulation of splanchnic glucose output and ketogenesis in insulin-deficient humans.
    Björkman O; Felig P; Wahren J
    Clin Physiol; 1984 Jun; 4(3):227-41. PubMed ID: 6146427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of insulin deficiency on glucose fluxes and muscle glucose metabolism during exercise.
    Wasserman DH; Mohr T; Kelly P; Lacy DB; Bracy D
    Diabetes; 1992 Oct; 41(10):1229-38. PubMed ID: 1356861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ketone bodies on basal and insulin-stimulated glucose utilization in man.
    Beylot M; Khalfallah Y; Riou JP; Cohen R; Normand S; Mornex R
    J Clin Endocrinol Metab; 1986 Jul; 63(1):9-15. PubMed ID: 3519651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.
    Pontiroli AE; Perfetti MG; Andreotti AC; Fattor B; Monti LD; Pozza G
    Metabolism; 1993 Oct; 42(10):1242-8. PubMed ID: 8105365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of glucagon in countering hypoglycemia induced by insulin infusion in dogs.
    Dobbins RL; Connolly CC; Neal DW; Palladino LJ; Parlow AF; Cherrington AD
    Am J Physiol; 1991 Dec; 261(6 Pt 1):E773-81. PubMed ID: 1767838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.
    Wahren J; Efendić S; Luft R; Hagenfeldt L; Björkman O; Felig P
    J Clin Invest; 1977 Feb; 59(2):299-307. PubMed ID: 833277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of small variations in insulin and glucagon levels on plasma aminoacids concentrations.
    Beylot M; Chambrier C; Moneger A; Cohen R
    Diabete Metab; 1989; 15(1):38-44. PubMed ID: 2566520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
    Sandhu H; Wiesenthal SR; MacDonald PE; McCall RH; Tchipashvili V; Rashid S; Satkunarajah M; Irwin DM; Shi ZQ; Brubaker PL; Wheeler MB; Vranic M; Efendic S; Giacca A
    Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise-induced changes in insulin and glucagon are not required for enhanced hepatic glucose uptake after exercise but influence the fate of glucose within the liver.
    Pencek RR; James FD; Lacy DB; Jabbour K; Williams PE; Fueger PT; Wasserman DH
    Diabetes; 2004 Dec; 53(12):3041-7. PubMed ID: 15561932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.
    Boden G; Cheung P; Stein TP; Kresge K; Mozzoli M
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E12-9. PubMed ID: 12067837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man.
    Wu MS; Ho LT
    Horm Metab Res; 1987 Jun; 19(6):253-6. PubMed ID: 2887501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.
    Fanelli C; Calderone S; Epifano L; De Vincenzo A; Modarelli F; Pampanelli S; Perriello G; De Feo P; Brunetti P; Gerich JE
    J Clin Invest; 1993 Oct; 92(4):1617-22. PubMed ID: 8408616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.